Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experiences with the Haemonetics cell saver]

P Klaue

    Anasthesie, Intensivtherapie, Notfallmedizin
    |August 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    The Haemonetics Cell Saver provides effective autotransfusion, recovering 53% of red blood cells (RBCs) for patient use. This method successfully removed impurities, maintaining patient homeostasis during and after surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Subjective sequelae of splenectomy].

    Langenbecks Archiv fur Chirurgie·1990
    Same author

    [Value of diagnostic peritoneal lavage in blunt abdominal trauma].

    Der Unfallchirurg·1986
    Same author

    [Possibilities with enteral tube feeding in surgery].

    Krankenpflege Journal·1986
    Same author

    [Long-term sequelae of splenic loss].

    Langenbecks Archiv fur Chirurgie·1986
    Same author

    [Treatment of splenic rupture].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·1985
    Same author

    pH-control via secretin or antacid: prophylaxia of stress ulcers in high-risk surgical patients.

    Intensive care medicine·1984

    Area of Science:

    • Medical devices
    • Transfusion medicine
    • Surgical innovation

    Context:

    • Autotransfusion is a critical component of modern surgical practice.
    • The Haemonetics Cell Saver represents a technological advancement in blood management.
    • Evaluating its efficacy in real-world clinical settings is essential.

    Purpose:

    • To assess the efficacy and recovery rates of the Haemonetics Cell Saver for intraoperative and intensive care unit autotransfusion.
    • To determine the quality of recovered red blood cells (RBCs) and the elimination of contaminants.
    • To investigate the impact of autotransfusion on patient homeostasis and coagulation parameters.

    Summary:

    • The Haemonetics Cell Saver was utilized in 25 patients, collecting 47.7 liters of blood loss.

    Related Experiment Videos

  • This resulted in 17.8 liters of washed RBC concentrates, achieving a 53% recovery rate of RBC loss.
  • The system effectively removed activators of haemostasis and cell debris, with minimal impact on cellular and fluid homeostasis.

    • Impact:

    • Demonstrates the clinical utility of the Haemonetics Cell Saver in improving RBC recovery during surgery.
    • Highlights the potential for reduced reliance on allogeneic blood transfusions.
    • Provides data on the safety and effectiveness of autotransfusion in diverse patient populations.